Literature DB >> 27400069

Is there really a specific graft-versus-leukaemia effect?

R P Gale1, E J Fuchs2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27400069     DOI: 10.1038/bmt.2016.183

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  14 in total

1.  NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Authors:  Howard M Shulman; Diana M Cardona; Joel K Greenson; Sangeeta Hingorani; Thomas Horn; Elisabeth Huber; Andreas Kreft; Thomas Longerich; Thomas Morton; David Myerson; Victor G Prieto; Avi Rosenberg; Nathaniel Treister; Kay Washington; Mirjana Ziemer; Steven Z Pavletic; Stephanie J Lee; Mary E D Flowers; Kirk R Schultz; Madan Jagasia; Paul J Martin; Georgia B Vogelsang; David E Kleiner
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-29       Impact factor: 5.742

2.  Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study.

Authors:  Joseph Pidala; Georgia Vogelsang; Paul Martin; Xiaoyu Chai; Barry Storer; Steven Pavletic; Daniel J Weisdorf; Madan Jagasia; Corey Cutler; Jeanne Palmer; David Jacobsohn; Sally Arai; Stephanie J Lee
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

Review 3.  Commentary: does immune suppression increase risk of developing acute myeloid leukemia?

Authors:  R P Gale; G Opelz
Journal:  Leukemia       Date:  2011-08-26       Impact factor: 11.528

4.  Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303.

Authors:  Steven M Devine; Shelly Carter; Robert J Soiffer; Marcelo C Pasquini; Parameswaran N Hari; Anthony Stein; Hillard M Lazarus; Charles Linker; Edward A Stadtmauer; Edwin P Alyea; Carolyn A Keever-Taylor; Richard J O'Reilly
Journal:  Biol Blood Marrow Transplant       Date:  2011-02-12       Impact factor: 5.742

5.  Graft-versus-leukemia reactions after bone marrow transplantation.

Authors:  M M Horowitz; R P Gale; P M Sondel; J M Goldman; J Kersey; H J Kolb; A A Rimm; O Ringdén; C Rozman; B Speck
Journal:  Blood       Date:  1990-02-01       Impact factor: 22.113

6.  Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.

Authors:  Michael R Verneris; Claudio G Brunstein; Juliet Barker; Margaret L MacMillan; Todd DeFor; David H McKenna; Michael J Burke; Bruce R Blazar; Jeffrey S Miller; Philip B McGlave; Daniel J Weisdorf; John E Wagner
Journal:  Blood       Date:  2009-08-25       Impact factor: 22.113

Review 7.  Modern approaches to HLA-haploidentical blood or marrow transplantation.

Authors:  Christopher G Kanakry; Ephraim J Fuchs; Leo Luznik
Journal:  Nat Rev Clin Oncol       Date:  2015-08-25       Impact factor: 66.675

8.  Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia.

Authors:  Mohini Rajasagi; Sachet A Shukla; Edward F Fritsch; Derin B Keskin; David DeLuca; Ellese Carmona; Wandi Zhang; Carrie Sougnez; Kristian Cibulskis; John Sidney; Kristen Stevenson; Jerome Ritz; Donna Neuberg; Vladimir Brusic; Stacey Gabriel; Eric S Lander; Gad Getz; Nir Hacohen; Catherine J Wu
Journal:  Blood       Date:  2014-06-02       Impact factor: 22.113

9.  Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation.

Authors:  Marcelo C Pasquini; Steven Devine; Adam Mendizabal; Lindsey R Baden; John R Wingard; Hillard M Lazarus; Frederick R Appelbaum; Carolyn A Keever-Taylor; Mary M Horowitz; Shelly Carter; Richard J O'Reilly; Robert J Soiffer
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

10.  Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies.

Authors:  T L Kindwall-Keller; Y Hegerfeldt; H J Meyerson; S Margevicius; P Fu; W van Heeckeren; H M Lazarus; B W Cooper; S L Gerson; P Barr; W W Tse; C Curtis; L R Fanning; R J Creger; J M Carlson-Barko; M J Laughlin
Journal:  Bone Marrow Transplant       Date:  2011-10-17       Impact factor: 5.483

View more
  3 in total

1.  Will immune therapy cure acute myeloid leukemia?

Authors:  Robert Peter Gale
Journal:  Blood Sci       Date:  2019-09-17

2.  Mesenchymal stromal cells and leukemia therapy in mice and man.

Authors:  Robert Peter Gale
Journal:  Blood Sci       Date:  2020-06-24

3.  NK Cells and γδT Cells for Relapse Protection After Allogeneic Hematopoietic Cell Transplantation (HCT).

Authors:  Moniek A de Witte; Jürgen Kuball; Jeffrey S Miller
Journal:  Curr Stem Cell Rep       Date:  2017-10-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.